{"product_id":"ss-31-cardiogen-30-mg-pen","title":"SS-31 + CARDIOGEN | 30 Mg Pen","description":"\u003cp class=\"p1\"\u003eSS-31 (Elamipretide) is a mitochondria-targeting peptide studied for its role in cellular energy regulation and oxidative stress pathways, while Cardiogen is a peptide studied in cardiac-tissue research for its involvement in myocardial signaling and cardiovascular support models. Together, this combination is evaluated in research environments focused on mitochondrial function, cardiac-cell activity, and systemic energy dynamics. Information on this page is provided for scientific and educational context only and does not represent medical guidance or therapeutic claims.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eSUPPORTS\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eMitochondrial function assessed via ATP production and oxidative phosphorylation markers.\u003cbr\u003eCellular energy regulation studied through bioenergetic and metabolic endpoints.\u003cbr\u003eCardiac-cell signaling evaluated in myocardial tissue research frameworks.\u003cbr\u003eOxidative stress response measured via reactive oxygen species and redox balance markers.\u003cbr\u003eCardiovascular system support studied through heart-function and tissue-response models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eDESCRIPTION\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eSS-31, also known as Elamipretide, is a peptide studied for its ability to target mitochondria and interact with cardiolipin, a key phospholipid in the inner mitochondrial membrane. This interaction has been explored in research models where improved mitochondrial efficiency and reduced oxidative stress are measured. Cardiogen is a peptide studied for its potential role in cardiac-tissue signaling and myocardial support within experimental frameworks. In combination, SS-31 and Cardiogen form a dual-pathway system focused on cellular energy production and cardiovascular-related signaling. This blend is used in research environments investigating how mitochondrial performance and cardiac function interact at the cellular level. This product is presented for controlled research and educational context only and is not marketed as a therapeutic intervention.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eCLINICAL STATUS\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eSS-31 has been studied in both clinical and preclinical settings, particularly in mitochondrial dysfunction and cardiovascular-related research. Cardiogen research is primarily preclinical and mechanistic. The combined formulation remains within experimental research contexts and is not approved as a general therapeutic product.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003eEvidence type: Human RCT ✔ (SS-31) | Observational ✔ | Animal ✔ | In vitro ✔ | Regulatory approval ✘\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eMECHANISM OF ACTION\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eMechanistic models of SS-31 focus on its selective targeting of mitochondrial membranes, where it binds to cardiolipin and stabilizes electron transport chain function, improving ATP production and reducing reactive oxygen species. Cardiogen is studied for its interaction with signaling pathways associated with cardiac-cell activity and myocardial function. Together, the peptides are evaluated as a system that supports cellular energy efficiency while influencing cardiac-related signaling pathways. Effects are measured through mitochondrial performance markers, oxidative stress indicators, and cardiac-cell activity models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eBENEFITS\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eMitochondrial Efficiency Research: SS-31 is studied for improving mitochondrial function and ATP production.\u003cbr\u003eCellular Energy Support: Evaluated in models focused on bioenergetics and energy utilization.\u003cbr\u003eCardiac Signaling Research: Cardiogen is studied for its effects on myocardial-cell communication.\u003cbr\u003eOxidative Stress Reduction: Research indicates reduced reactive oxygen species in mitochondrial models.\u003cbr\u003eCardiovascular Research Applications: Explored in models assessing heart-related cellular activity.\u003cbr\u003eDual-System Integration: Combines mitochondrial targeting with cardiac signaling pathways in one framework.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eRESEARCH DATA\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eStudy\/model | Reported effect\u003cbr\u003eMitochondrial function studies | Improved ATP production and reduced oxidative stress observed\u003cbr\u003eCardiac-cell models | Enhanced signaling and cellular response in myocardial tissue\u003cbr\u003ePreclinical cardiovascular studies | Improved cellular energy and function markers\u003cbr\u003eIn vitro assays | Stabilization of mitochondrial membranes and reduced ROS levels\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eSTACK SUGGESTIONS\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eNAD+ (cellular energy and mitochondrial function models)\u003cbr\u003eCoQ10 (electron transport chain and oxidative balance research)\u003cbr\u003eGlutathione (redox balance and oxidative stress studies)\u003cbr\u003eStacks discussed are for experimental design only, not safety or efficacy guidance.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003ePOSSIBLE SIDE EFFECTS\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eInjection-site reactions including redness or discomfort\u003cbr\u003eTransient fatigue or energy fluctuations\u003cbr\u003eMild systemic adjustments depending on protocol\u003cbr\u003eResponses vary depending on experimental conditions\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eSCIENTIFIC REFERENCES\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eSS-31 mitochondrial targeting studies — Clinical and preclinical research\u003cbr\u003eCardiolipin interaction and mitochondrial function — Mechanistic studies\u003cbr\u003eCardiac-cell signaling research — Experimental models\u003cbr\u003eOxidative stress and mitochondrial efficiency — Translational data\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003cspan class=\"s1\"\u003e\u003cb\u003eCAUTIONS\u003c\/b\u003e\u003c\/span\u003e\u003cbr\u003eFor educational and scientific context only; not intended to diagnose, treat, cure, or prevent any disease. Not approved for general medical use. Outcomes vary based on experimental design and physiological conditions. Consult a qualified professional for any health-related decisions.\u003c\/p\u003e","brand":"Peptoora","offers":[{"title":"Default Title","offer_id":61715368837450,"sku":null,"price":529.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0887\/1139\/7706\/files\/SS-31_Cardiogenmix.png?v=1777289031","url":"https:\/\/peptoora.com\/products\/ss-31-cardiogen-30-mg-pen","provider":"Peptoora LTD","version":"1.0","type":"link"}